The Taskforce on Innovation, Growth and Regulatory Reform (TIGRR) reported its recommendations to the Prime Minister on how the UK can reshape regulation and seize new opportunities from Brexit. We welcome the key recommendations relating to the cannabinoid sector, in particular the proposal to move the licensing regime for cannabinoid clinical research and consumer cannabinoids from the Home Office to Department of Health and Social Care (DHSC) and Medicines and Healthcare products Regulatory Agency (MHRA). As the report acknowledges, the present rules governing these medicinal and nutraceutical products are not properly separated from the criminal law relating to banned substances derived from cannabis.
This recommendation was a central proposal of the CMC and ACI in our submission to the Taskforce with the follow up report Green Shoots and at this exclusive members only webinar we will hear from the authors and contributors of that report. We will dissect the TIGGR report and gain a true understanding of how we can unleash the much needed investment in cannabinoid medicines and consumer CBD products.
Our event will be chaired by Dr Elisabeth Phillips, Neuroscientist and CBD Expert and MP George Freeman, who is leading the PM’s TIGGR Taskforce
Our expert panel will include:
- Dr Parveen Bhatarah, CMC Regulatory and Compliance Associate
- Dr Andy Yates, CMC Pharmacy Lead
- Dr Daniel Couch, CMC Medical Lead
- With comment from the team at Political Insight
Monday, June 21, 2021
4:00 PM 5:30 PM BST
